Ikonisys Inc., of New Haven, Conn., appointed Paul Marks to its scientific advisory board.
La Jolla Pharmaceutical Co., of San Diego, promoted Gail Sloan to vice president of finance, controller and secretary.
Lipid Sciences Inc., of Pleasanton, Calif., elected Bosko Djordjevic to its board.
NaPro BioTherapeutics Inc., of Boulder, Colo, appointed Stephen Carter to its board.
NeuroMed Technologies Inc., of Vancouver, British Columbia, appointed William Hunter to its board.
Novacea Inc., of South San Francisco, appointed Edward Albini vice president and chief financial officer.
NovaDel Pharma Inc., of Flemington, N.J., named Robert Savage to its board.
Nuvelo Inc., of Sunnyvale, Calif., appointed Steven Deitcher vice president of medical affairs.
Pacific Growth Equities, of San Francisco, promoted Thomas Dietz and Stephen Massocca to co-CEOs.
Pharmexa, of Hoersholm, Denmark, named Jakob Schmidt CEO, Iben Dalum chief scientific officer, Dana Leach chief operating officer and Hans Henrik Chrois Christensen chief financial officer.
Provectus Pharmaceuticals Inc., of Knoxville, Tenn., appointed Gregory Bailey to the corporate advisory board.
Quintiles Transnational Corp., of Research Triangle Park, N.C., appointed the following people to its board: Dennis Gillings, Richard Cashin, Clateo Castellini, Jonathan Coslet, Jack Greenberg, Robert Ingram, S. Iswaran, Jacques Nasser, James Rubin and James Bierman.
Rockeby biomed Ltd., of Sydney, Australia, appointed David Free and Swan Jeng Tan to its board.
Salmedix Inc., of San Diego, appointed Pratik Multani vice president of clinical development.
Scion Pharmaceuticals Inc., of Medford, Mass., appointed Valentin Gribkoff vice president of biology.
StemCells Inc., of Palo Alto, Calif., elected Eric Bjerkholt to its board.
ThinkEquity Partners, of San Francisco, appointed Michael Staiger principal covering institutional accounts on the West Coast.
Threshold Pharmaceuticals, of South San Francisco, appointed Allen Venook and James Abbruzzese to its scientific advisory board.
Vaxin Inc., of Birmingham, Ala., appointed Francis Cano CEO and chairman.
Vicuron Pharmaceuticals Inc., of King of Prussia, Pa., hired Robert Radie as senior vice president of sales.